What is the new HER2-positive breast cancer drug 'Tukysa'? — Mechanism of action, usage, and the meaning of the 81% side effect figure

In 2026, a new treatment for HER2-positive breast cancer, 'Tukysa' (generic name: tucatinib), was approved in Japan.I am ...